• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在正常乳腺细胞和肿瘤来源的乳腺细胞中,BRCA1表达在DNA合成之前被诱导。

BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

作者信息

Vaughn J P, Davis P L, Jarboe M D, Huper G, Evans A C, Wiseman R W, Berchuck A, Iglehart J D, Futreal P A, Marks J R

机构信息

Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Cell Growth Differ. 1996 Jun;7(6):711-5.

PMID:8780884
Abstract

Insight into the function of the BRCA1 tumor suppressor gene may be gained by studying its regulation. In this study, the expression of BRCA1 was examined as a function of the cell cycle in normal and tumor-derived breast epithelial cells. Cells arrested in G(zero) or early in G1 contained low levels of BRCA1 mRNA. After release, populations of cells reached maximal levels of BRCA1 in late G1 and S phase. Induction of BRCA1 was shown to occur before the onset of DNA synthesis by synchronizing cells at the G1-S boundary. Levels of the BRCA1 protein were regulated in a similar manner. No difference was observed between primary cultures of normal mammary epithelial cells and immortalized tumor-derived cell lines. These results suggest that BRCA1 may function at the G1-S checkpoint.

摘要

通过研究BRCA1肿瘤抑制基因的调控机制,或许可以深入了解其功能。在本研究中,我们检测了正常乳腺上皮细胞和肿瘤来源的乳腺上皮细胞中BRCA1的表达随细胞周期的变化情况。停滞于G(零)期或G1早期的细胞中BRCA1 mRNA水平较低。解除停滞状态后,细胞群体在G1晚期和S期达到BRCA1的最高水平。通过将细胞同步于G1-S边界,发现BRCA1的诱导发生在DNA合成开始之前。BRCA1蛋白水平也以类似方式受到调控。在正常乳腺上皮细胞的原代培养物和永生化肿瘤来源细胞系之间未观察到差异。这些结果表明,BRCA1可能在G1-S检查点发挥作用。

相似文献

1
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.在正常乳腺细胞和肿瘤来源的乳腺细胞中,BRCA1表达在DNA合成之前被诱导。
Cell Growth Differ. 1996 Jun;7(6):711-5.
2
Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.人乳腺上皮细胞中BRCA1信使核糖核酸的细胞周期调控
Cell Growth Differ. 1996 Jun;7(6):717-23.
3
Cell cycle control of BRCA2.BRCA2的细胞周期调控
Cancer Res. 1996 Oct 15;56(20):4590-4.
4
Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.BRCA1剪接变体在异步及G1/S期同步化肿瘤细胞系中的表达谱
Biochem Biophys Res Commun. 2001 Jan 12;280(1):32-8. doi: 10.1006/bbrc.2000.4068.
5
Changes in BRCA2 expression during progression of the cell cycle.细胞周期进程中BRCA2表达的变化。
Biochem Biophys Res Commun. 1997 May 8;234(1):247-51. doi: 10.1006/bbrc.1997.6544.
6
Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation.通过一种新方法分离出的同基因正常基底和管腔乳腺上皮细胞对电离辐射表现出不同的反应。
Cancer Res. 2007 Apr 1;67(7):2990-3001. doi: 10.1158/0008-5472.CAN-06-4065.
7
Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.一种携带BRCA1基因185delAG突变的乳腺细胞系的建立与鉴定
Gynecol Oncol. 2000 Apr;77(1):121-8. doi: 10.1006/gyno.2000.5734.
8
Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma.γ-干扰素可诱导乳腺上皮细胞在G1期中期发生不可逆的生长停滞,这与视网膜母细胞瘤蛋白的过度磷酸化受阻相关。
Cell Growth Differ. 1996 Mar;7(3):289-300.
9
Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.维甲酸可诱导培养的正常人乳腺上皮细胞及人乳腺癌细胞系中白细胞介素-1β基因的表达。
J Cell Physiol. 2002 Nov;193(2):244-52. doi: 10.1002/jcp.10173.
10
The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.1α,25(OH)₂D₃对乳腺癌和前列腺癌细胞的抗增殖作用与BRCA1基因表达的诱导有关。
Oncogene. 2000 Oct 19;19(44):5091-7. doi: 10.1038/sj.onc.1203888.

引用本文的文献

1
Aberrant accumulation of phosphorylated BRCA1 in brainstem-type and cortical-type Lewy bodies in Lewy body disease.在路易体病的脑干型和皮质型路易小体中,磷酸化BRCA1异常积聚。
J Neuropathol Exp Neurol. 2025 Apr 1;84(4):276-285. doi: 10.1093/jnen/nlaf004.
2
A transcription-independent mechanism determines rapid periodic fluctuations of BRCA1 expression.一种转录独立性机制决定了 BRCA1 表达的快速周期性波动。
EMBO J. 2023 Aug 1;42(15):e111951. doi: 10.15252/embj.2022111951. Epub 2023 Jun 19.
3
BRCA1: An Endocrine and Metabolic Regulator.
乳腺癌1号基因(BRCA1):一种内分泌和代谢调节因子。
Front Endocrinol (Lausanne). 2022 Mar 31;13:844575. doi: 10.3389/fendo.2022.844575. eCollection 2022.
4
Insights into the non-mitotic functions of Aurora kinase A: more than just cell division.极光激酶 A 的非有丝分裂功能解析:远不止于细胞分裂。
Cell Mol Life Sci. 2020 Mar;77(6):1031-1047. doi: 10.1007/s00018-019-03310-2. Epub 2019 Sep 27.
5
Non-Coding Variants in and Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.BRCA1和BRCA2基因中的非编码变异:对乳腺癌和卵巢癌易感性的潜在影响。
Cancers (Basel). 2018 Nov 16;10(11):453. doi: 10.3390/cancers10110453.
6
The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.BET 抑制剂 INCB054329 降低卵巢癌细胞中同源重组效率并增强 PARP 抑制剂的活性。
Gynecol Oncol. 2018 Jun;149(3):575-584. doi: 10.1016/j.ygyno.2018.03.049. Epub 2018 Mar 20.
7
Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells.极光激酶A调节卵巢癌细胞中的非同源末端连接和聚(ADP-核糖)聚合酶功能。
Oncotarget. 2017 Jul 5;8(31):50376-50392. doi: 10.18632/oncotarget.18970. eCollection 2017 Aug 1.
8
A TGFβ-miR-182-BRCA1 axis controls the mammary differentiation hierarchy.转化生长因子β-微小RNA-182-乳腺癌1号基因轴控制乳腺分化层级。
Sci Signal. 2016 Dec 6;9(457):ra118. doi: 10.1126/scisignal.aaf5402.
9
Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.利用CRISPR/Cas技术构建对类似物敏感的CDK12细胞系。
Biochim Biophys Acta. 2015 Sep;1849(9):1179-87. doi: 10.1016/j.bbagrm.2015.07.010. Epub 2015 Jul 17.
10
Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle.生理调节内源性 BRCA1 p220 丰度可抑制细胞周期中的 DNA 损伤。
Genes Dev. 2013 Oct 15;27(20):2274-91. doi: 10.1101/gad.225045.113.